|
Regulation of Fibronectin Matrix Assembly by uPAR
|
5R01CA058626-18
|
$272,648
|
$136,324
|
MC KEOWN-LONGO, PAULA
|
ALBANY MEDICAL COLLEGE
|
|
Novel Strategies for Precision T-cell Therapies
|
5R01CA198095-03
|
$520,564
|
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
(7) Novel imaging devices for measurement and control of tumor microenvironments
|
5R01CA216248-02
|
$607,904
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The B7x pathway in the tumor microenvironment
|
5R01CA175495-06
|
$346,525
|
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
RTOG Biospecimen Repository
|
2U24CA114734-06
|
$1,040,063
|
$104,006
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RTOG Tissue Bank
|
3U24CA114734-05S2
|
|
$0
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Arizona Cancer and Evolution Center (ACE)
|
1U54CA217376-01A1
|
$1,906,167
|
|
MALEY, CARLO
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
IDO-Expressing Immunoregulatory Dendritic Cells
|
5R01CA103320-15
|
$307,800
|
|
MUNN, DAVID
|
AUGUSTA UNIVERSITY
|
|
Development of cell-free DNA assays for HCC screening and liquid biopsy
|
5R01CA202769-03
|
$397,877
|
|
SU, YING-HSIU
|
BARUCH S. BLUMBERG INSTITUTE
|
|
Pediatric Oncology Clinical Research Training Program
|
5K12CA090433-17
|
$827,164
|
|
BLANEY, SUSAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Discovery, Biology and Risk of Inherited Variants in Glioma
|
1R01CA217105-01A1
|
$1,043,807
|
|
BONDY, MELISSA
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection
|
5R01CA206476-03
|
$706,386
|
|
CHIAO, ELIZABETH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mechanisms of KLF4 suppression in pediatric leukemia
|
5R01CA207086-02
|
$370,641
|
|
LACORAZZA, DANIEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
5R01CA215452-02
|
$362,569
|
$181,284
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
THE INITIATION AND REGULATION OF INFLAMMATION IN NEUROBLASTOMA
|
5R01CA116548-13
|
$249,638
|
|
METELITSA, LEONID
|
BAYLOR COLLEGE OF MEDICINE
|
|
Metabolic Regulation in Leukemia-Initatiating Cells
|
5R01CA193235-04
|
$462,191
|
|
NAKADA, DAISUKE
|
BAYLOR COLLEGE OF MEDICINE
|
|
De facto Target of Histone Deacetylase Inhibitors
|
5R21CA215591-02
|
$172,369
|
|
SUN, ZHENG
|
BAYLOR COLLEGE OF MEDICINE
|
|
Drugging the Undruggable Coactivators using Small Molecule Inhibitors
|
5R01CA207701-02
|
$426,451
|
|
WANG, JIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
METHYLATION BIOMARKER DEVELOPMENT FOR NONINVASIVE DETECTION OF COLORECTAL CANCER
|
5R01CA181572-05
|
$319,735
|
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
|
5R01CA155769-07
|
$410,877
|
|
BADIE, BEHNAM
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
The role and mechanism of FTO in leukemogenesis and drug response
|
5R01CA214965-03
|
$444,571
|
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
|
5R01CA213138-02
|
$395,738
|
|
MUSCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
5R21CA205106-02
|
$176,605
|
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Multimedia Self-Management Intervention to Prepare Family Caregivers and Patients for Lung Cancer Surgery
|
1R01CA217841-01A1
|
$717,367
|
|
SUN, VIRGINIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Molecular Mechanisms of BRCA1-Dependent DNA Damage Response and Tumorogenesis
|
5R01CA132755-11
|
$382,500
|
|
YU, XIAOCHUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Humanized Anti-Renalase Antibodies for Unresectable Melanoma
|
1R43CA224463-01
|
$299,996
|
|
BERKOWITZ, BARRY
|
BESSOR PHARMA, LLC
|
|
Isolation and Assessment of Blood-Circulating Cancer Exosomes with LSS and SERS Lab on a Chip Optical Spectroscopic Instrument
|
1R01CA218382-01A1
|
$668,549
|
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
(PQ7) In Vivo Cellular Optical Imaging of Esophageal Tumors and Microenvironment
|
5R01CA205431-03
|
$522,325
|
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Randomized Trial of a Mammography Decision Aid for Women Aged 75 and Older
|
5R01CA181357-05
|
$414,552
|
|
SCHONBERG, MARA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Dissecting sarcoma complexity via innovative microRNA and informatics approaches
|
5K22CA138716-02
|
$191,160
|
$191,160
|
Spentzos, Dimitrios
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Characterizing the signaling pathways that regulate Skp2 oncogenic function
|
5R01CA200573-03
|
$395,738
|
|
WEI, WENYI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Cancer Deep Phenotype Extraction from Electronic Medical Records
|
5U24CA184407-06
|
$993,015
|
|
SAVOVA, GUERGANA
|
BOSTON CHILDREN'S HOSPITAL
|
|
Role of c-Cbl in Colon cancer
|
5R01CA175382-05
|
$361,050
|
|
CHITALIA, VIPUL
|
BOSTON MEDICAL CENTER
|
|
TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE
|
1R01CA227433-01
|
$608,862
|
|
GRINSTAFF, MARK
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor
|
5R01CA138509-10
|
$368,325
|
|
REINHARD, BJOERN
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
Functional characterization of the telomere repeat containing RNA, TERRA, in telomere maintenance
|
5R01CA214880-02
|
$237,158
|
$237,158
|
FLYNN, RACHEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-05
|
$8,073,787
|
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Integrative genomic framework for dissecting regulatory mechanisms underlying hepatocellular carcinoma
|
5R21CA209940-02
|
$175,001
|
|
POCHET, NATHALIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Redefining Normal: personalized CA125 cutpoints for ovarian cancer screening
|
5R01CA193965-03
|
$371,704
|
|
TERRY, KATHRYN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Calcium and Colorectal Cancer: Gene-Environment Interactions and Molecular Pathways
|
5K07CA188126-04
|
$144,000
|
|
ZHANG, XUEHONG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
PatientCareAnywhere: Patient Support and Empowerment Across the Care Continuum
|
5R44CA192588-04
|
$234,573
|
|
YANG, DERSHUNG
|
BRIGHTOUTCOME INC.
|
|
Genetic Determinants of Barretts Esophagus and Esophageal Adenocarcinoma
|
5U54CA163060-07
|
$1,283,594
|
|
CHAK, AMITABH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Oncology Nurse IMPACT:Improving Communication with Patients about Clinical Trial
|
5R25CA177574-05
|
$130,966
|
|
DALY, BARBARA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Identification and Targeting of Chemotherapy Refractory Small Cell Lung Cancer
|
1R21CA226322-01
|
$208,800
|
|
DOWLATI, AFSHIN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Clinical Oncology Research Program (CORP)
|
2K12CA076917-21
|
$945,630
|
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeted MRI contrast agents for differential diagnosis of prostate cancer
|
5R01CA211762-02
|
$424,315
|
|
LU, ZHENG-RONG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Computerized histologic image predictor of cancer outcome
|
5R01CA202752-03
|
$608,223
|
|
MADABHUSHI, ANANT
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus
|
5U01CA152756-08
|
$706,863
|
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Small Molecule Activators of PP2A (SMAPs) for Prostate Cancer Therapy
|
5R01CA181654-04
|
$374,305
|
|
NARLA, GOUTHAM
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Mechanisms of metabolic reprogramming by PIK3CA oncogenic mutations
|
5R01CA196643-03
|
$383,725
|
|
WANG, ZHENGHE
|
CASE WESTERN RESERVE UNIVERSITY
|
Total relevant funding to Sarcoma for this search: $59,150,263
|